Molecular Docking and Dynamics Studies of Curcumin with COVID-19 Proteins

Overview

Journal Netw Model Anal Health Inform Bioinform

Specialty Biology

Date 2021 Jun 16

PMID 34131556

Citations 13

Authors

Renuka Suravajhala

Abhinav Parashar

Gourav Choudhir

Anuj Kumar

Babita Malik

Viswanathan Arun Nagaraj

Govindarajan Padmanaban

Rathnagiri Polavarapu

Prashanth Suravajhala

P B Kavi Kishor

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) is caused by a Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2), which is a positive-strand RNA virus. The SARS-CoV-2 genome and its association to SAR-CoV-1 vary from ca. 66 to 96% depending on the type of betacoronavirideae family members. With several drugs, viz. chloroquine, hydroxychloroquine, ivermectin, artemisinin, remdesivir, azithromycin considered for clinical trials, there has been an inherent need to find distinctive antiviral mechanisms of these drugs. Curcumin, a natural bioactive molecule has been shown to have therapeutic potential for various diseases, and its effect on COVID-19 is also currently being explored. In this study, we show the binding potential of curcumin targeted to a variety of SARS-CoV-2 proteins, viz spike glycoproteins (PDB ID: 6VYB), nucleocapsid phosphoprotein (PDB ID: 6VYO), spike protein-ACE2 (PDB ID: 6M17) along with nsp10 (PDB ID: 6W4H) and RNA dependent RNA polymerase (PDB ID: 6M71) structures. Furthermore, representative docking complexes were validated using molecular dynamics simulations and mechanistic studies at 100 ns was carried on nucleocapsid and nsp10 proteins with curcumin complexes which resulted in stable and efficient binding energies and correlated with that of docked binding energies of the complexes. Both the docking and simulation studies indicate that curcumin has the potential as an antiviral against COVID-19.

Citing Articles

COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals.

De Souza Goncalves B, Sangani D, Nayyar A, Puri R, Irtiza M, Nayyar A Int J Mol Sci. 2024; 25(15).

PMID: 39126050 PMC: 11312872. DOI: 10.3390/ijms25158481.

Curcumin-derived carbon-dots as a potential COVID-19 antiviral drug.

Fibriani A, Taharuddin A, Stephanie R, Yamahoki N, Laurelia J, Wisnuwardhani P Heliyon. 2023; 9(9):e20089.

PMID: 37809799 PMC: 10559838. DOI: 10.1016/j.heliyon.2023.e20089.

A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products.

Rafiq A, Jabeen T, Aslam S, Ahmad M, Ashfaq U, Mohsin N Molecules. 2023; 28(12).

PMID: 37375415 PMC: 10305344. DOI: 10.3390/molecules28124860.

Neurological damages in COVID-19 patients: Mechanisms and preventive interventions.

Sarkar S, Karmakar S, Basu M, Ghosh P, Ghosh M MedComm (2020). 2023; 4(2):e247.

PMID: 37035134 PMC: 10080216. DOI: 10.1002/mco2.247.

A review on computer-aided chemogenomics and drug repositioning for rational COVID-19 drug discovery.

Maghsoudi S, Taghavi Shahraki B, Rameh F, Nazarabi M, Fatahi Y, Akhavan O Chem Biol Drug Des. 2022; 100(5):699-721.

PMID: 36002440 PMC: 9539342. DOI: 10.1111/cbdd.14136.

References

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

Hilgenfeld R . From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014; 281(18):4085-96. PMC: 7163996. DOI: 10.1111/febs.12936. View

Balasco N, Esposito L, De Simone A, Vitagliano L . Role of loops connecting secondary structure elements in the stabilization of proteins isolated from thermophilic organisms. Protein Sci. 2013; 22(7):1016-23. PMC: 3719095. DOI: 10.1002/pro.2279. View

Su D, Lou Z, Sun F, Zhai Y, Yang H, Zhang R . Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J Virol. 2006; 80(16):7902-8. PMC: 1563834. DOI: 10.1128/JVI.00483-06. View

Soleimani V, Sahebkar A, Hosseinzadeh H . Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother Res. 2018; 32(6):985-995. DOI: 10.1002/ptr.6054. View

Abraham M, Gready J . Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J Comput Chem. 2011; 32(9):2031-40. DOI: 10.1002/jcc.21773. View

Liu Z, Ying Y . The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia. Front Cell Dev Biol. 2020; 8:479. PMC: 7303286. DOI: 10.3389/fcell.2020.00479. View

Yang M, Lee G, Si J, Lee S, You H, Ko G . Curcumin Shows Antiviral Properties against Norovirus. Molecules. 2016; 21(10). PMC: 6274093. DOI: 10.3390/molecules21101401. View

Walls A, Tortorici M, Snijder J, Xiong X, Bosch B, Rey F . Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc Natl Acad Sci U S A. 2017; 114(42):11157-11162. PMC: 5651768. DOI: 10.1073/pnas.1708727114. View

10.

Xia M, Ye Z, Shi Y, Zhou L, Hua Y . Curcumin improves diabetes mellitus‑associated cerebral infarction by increasing the expression of GLUT1 and GLUT3. Mol Med Rep. 2017; 17(1):1963-1969. DOI: 10.3892/mmr.2017.8085. View

11.

OBoyle N, Banck M, James C, Morley C, Vandermeersch T, Hutchison G . Open Babel: An open chemical toolbox. J Cheminform. 2011; 3:33. PMC: 3198950. DOI: 10.1186/1758-2946-3-33. View

12.

Chen Y, Su C, Ke M, Jin X, Xu L, Zhang Z . Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 2011; 7(10):e1002294. PMC: 3192843. DOI: 10.1371/journal.ppat.1002294. View

13.

Prasad S, Tyagi A, Aggarwal B . Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014; 46(1):2-18. PMC: 3918523. DOI: 10.4143/crt.2014.46.1.2. View

14.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

15.

Bosch B, van der Zee R, de Haan C, Rottier P . The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003; 77(16):8801-11. PMC: 167208. DOI: 10.1128/jvi.77.16.8801-8811.2003. View

16.

Zahedipour F, Hosseini S, Sathyapalan T, Majeed M, Jamialahmadi T, Al-Rasadi K . Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res. 2020; 34(11):2911-2920. PMC: 7276879. DOI: 10.1002/ptr.6738. View

17.

Bouvet M, Lugari A, Posthuma C, Zevenhoven J, Bernard S, Betzi S . Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J Biol Chem. 2014; 289(37):25783-96. PMC: 4162180. DOI: 10.1074/jbc.M114.577353. View

18.

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

19.

Padmanaban G, Nagaraj V . Curcumin May Defy Medicinal Chemists. ACS Med Chem Lett. 2017; 8(3):274. PMC: 5346972. DOI: 10.1021/acsmedchemlett.7b00051. View

20.

Dolati S, Ahmadi M, Aghebti-Maleki L, Nikmaram A, Marofi F, Rikhtegar R . Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacol Rep. 2018; 70(6):1158-1167. DOI: 10.1016/j.pharep.2018.05.008. View